Compare TWST & RYAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TWST | RYAN |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.6B |
| IPO Year | 2018 | 2021 |
| Metric | TWST | RYAN |
|---|---|---|
| Price | $89.09 | $42.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 17 |
| Target Price | $46.88 | ★ $50.88 |
| AVG Volume (30 Days) | 1.9M | ★ 2.2M |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.48% |
| EPS Growth | ★ 63.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $376,572,000.00 | ★ $3,051,126,000.00 |
| Revenue This Year | $18.91 | $15.78 |
| Revenue Next Year | $15.07 | $12.49 |
| P/E Ratio | ★ N/A | $86.72 |
| Revenue Growth | 20.32 | ★ 21.28 |
| 52 Week Low | $23.30 | $29.28 |
| 52 Week High | $105.47 | $66.27 |
| Indicator | TWST | RYAN |
|---|---|---|
| Relative Strength Index (RSI) | 51.79 | 64.11 |
| Support Level | $87.57 | $39.83 |
| Resistance Level | $105.47 | $42.48 |
| Average True Range (ATR) | 6.38 | 1.42 |
| MACD | -1.70 | 0.00 |
| Stochastic Oscillator | 20.10 | 73.49 |
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Ryan Specialty Holdings Inc is an international specialty insurance intermediary providing specialty products, solutions, and services for insurance brokers, agents, and carriers. The company offers wholesale insurance brokerage and delegated underwriting authority products and services, including distribution, underwriting, product development, administration, and risk management. Its expertise spans property, casualty, professional lines, transportation, personal lines, workers compensation, and employee benefits insurance, across traditional insurance and alternative risk solutions. The company operates in the United States and foreign markets, with the majority of revenue generated from the United States.